Asia-Pacific Blood Glucose Monitoring Market Introduction and Overview
According to SPER Market Research, the Asia-Pacific Blood Glucose Monitoring Market is estimated to reach USD 7.53 billion by 2033 with a CAGR of 7.98%.
The report includes an in-depth analysis of the Asia-Pacific Blood Glucose Monitoring Market, including market size and trends, product mix, distribution channels, and supplier analysis. Blood glucose monitoring devices are used to manage diabetes and check diabetic patients' blood glucose levels. These gadgets enable patients to monitor their blood glucose levels in a simple and non invasive way. The gadgets run a quantitative test and return data on the level of glucose in the blood. It assists individuals with managing the condition by monitoring their blood glucose levels and seeking medical attention when necessary.
- FEB 2023: The Dexcom G6 Continuous Glucose Monitoring Device is introduced in Singapore.
- MAR 2022: Quantum Operation Inc., a Tokyo-based healthcare IoT startup, unveiled the world's first non-invasive glucose monitor capable of continuous measuring. It takes blood sugar readings from the wrist with no pricks.
Market Opportunities and Challenges
Opportunities: The number of newly diagnosed cases of Type 1 and Type 2 diabetes is increasing, owing mostly to obesity, an unhealthy diet, and a lack of physical activity. This growth in diabetes cases, combined with an increase in healthcare spending, reflects the increased use of diabetic care products in industrialized countries. Furthermore, market expansion is also driven by the increasing use of insulin delivery devices and the rising prevalence of diabetes. To gain a major market share, leading manufacturers are prioritizing technological improvements and the creation of innovative products. As a result of these factors, the examined market is predicted to increase over the time of analysis.
Challenges: The blood glucose monitoring market in Asia-Pacific is faced with numerous challenges that hinder its expansion and advancement. The region's varied economic environments, which result in differing degrees of healthcare accessibility and infrastructure, are a major barrier. Lower economic development nations might find it difficult to embrace cutting-edge blood glucose monitoring technology, which would impede market penetration. Furthermore, standardization and smooth integration of blood glucose monitoring solutions are hampered by cultural variances and varying healthcare regulations. The availability of fake goods is another significant issue that has to be addressed since it can skew blood glucose tests and have an adverse effect on patient results.
Market Competitive Landscape
The blood glucose monitoring market in Asia-Pacific is highly fragmented, with a small number of significant manufacturers having a presence in the region's key nations. The remaining producers, on the other hand, continued to be restricted to the various regional or local markets. Companies were able to increase their market position in the recent past through player mergers and acquisitions.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User
|
| Regions covered | China, Japan, Australia, India, Rest of Asia Pacific
|
| Companies Covered | Abbott Diabetes Care, Acon, Agamatrix Inc., Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom, Johnson and Johnson (Lifescan), Medisana, Medtronic, Roche, Rossmax, Others
|
COVID-19 Impact on Asia-Pacific Blood Glucose Monitoring Market
The COVID-19 pandemic has a beneficial impact on the growth of the Asia-Pacific Diabetes Care Devices Market. Diabetes problems, aberrant glucose swings, and elevated blood glucose levels may be experienced by COVID-19-positive individuals with diabetes. The severity and mortality of COVID-19 increased significantly in people with diabetes, especially in those with poor glycemic control and type 1 (T1DM) or type 2 (T2DM) diabetes mellitus. Furthermore, the development of diabetes (T1DM and T2DM) and hyperglycemia has been associated with worse outcomes and has been found more frequently in the context of COVID-19.
Key Target Audience:
- Individuals with Diabetes
- Healthcare Professionals
- Pharmaceutical Companies
- Medical Device Manufacturers
- Hospitals and Clinics
- Research and Academic Institutions
- Health Insurance Providers
- Government Health Agencies
- Retail Pharmacies
- Diabetes Advocacy Organizations
Our in-depth analysis of the Asia-Pacific Blood Glucose Monitoring Market includes the following segments:
|
By Self-monitoring Blood Glucose Devices: |
Glucometer Devices
Test Strips
Lancets
|
|
By Continuous Glucose Monitoring Devices: |
Sensors
Durables
|
|
By End User: |
Hospital/Clinics
Home/Personal
|
Key Topics Covered in the Report:
- Asia-Pacific Blood Glucose Monitoring Market Size (FY’2024-FY’2033)
- Overview of Asia-Pacific Blood Glucose Monitoring Market
- Segmentation of Asia-Pacific Blood Glucose Monitoring Market By Self-monitoring Blood Glucose Devices (Glucometer Devices, Test Strips, Lancets)
- Segmentation of Asia-Pacific Blood Glucose Monitoring Market By Continuous Glucose Monitoring Devices (Sensors, Durables)
- Segmentation of Asia-Pacific Blood Glucose Monitoring Market By End User (Hospital/Clinics, Home/Personal)
- Expansion Analysis of Asia-Pacific Blood Glucose Monitoring Market
- Problems and Obstacles in Asia-Pacific Blood Glucose Monitoring Market
- Competitive Landscape in the Asia-Pacific Blood Glucose Monitoring Market
- Impact of COVID-19 and Demonetization on Asia-Pacific Blood Glucose Monitoring Market
- Details on Current Investment in Asia-Pacific Blood Glucose Monitoring Market
- Competitive Analysis of Asia-Pacific Blood Glucose Monitoring Market
- Prominent Players in the Asia-Pacific Blood Glucose Monitoring Market
- SWOT Analysis of Asia-Pacific Blood Glucose Monitoring Market
- Asia-Pacific Blood Glucose Monitoring Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Asia-Pacific Blood Glucose Monitoring Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Asia-Pacific Blood Glucose Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia-Pacific Blood Glucose Monitoring Market
7. Asia-Pacific Blood Glucose Monitoring Market, By Self-monitoring Blood Glucose Devices(USD Million)
7.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, By Self-monitoring Blood Glucose Devices, 2024-2033
7.2. Glucometer Devices
7.3. Test Strips
7.4. Lancets
8. Asia-Pacific Blood Glucose Monitoring Market, By Continuous Glucose Monitoring Devices (USD Million)
8.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, By Continuous Glucose Monitoring Devices, 2024-2033
8.2. Sensors
8.3. Durables
9. Asia-Pacific Blood Glucose Monitoring Market, By End User (USD Million)
9.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, End User, 2024-2033
9.2. Hospital/Clinics
9.3. Home/Personal
10. Asia-Pacific Blood Glucose Monitoring Market Forecast, 2020-2033 (USD Million)
10.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share
11. Asia-Pacific Blood Glucose Monitoring Market, By Self-monitoring Blood Glucose Devices, 2020-2033 (USD Million)
11.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Self-monitoring Blood Glucose Devices (2020-2026)
11.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Self-monitoring Blood Glucose Devices (2027-2033)
12. Asia-Pacific Blood Glucose Monitoring Market, By Continuous Glucose Monitoring Devices , 2020-2033 (USD Million)
12.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Continuous Glucose Monitoring Devices (2020-2026)
12.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Continuous Glucose Monitoring Devices (2027-2033)
13. Asia-Pacific Blood Glucose Monitoring Market, End User, 2020-2033 (USD Million)
13.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By End User (2020-2026)
13.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By End User (2027-2033)
14. Asia-Pacific Blood Glucose Monitoring Market, By Region, 2020-2033 (USD Million)
14.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Region (2020-2026)
14.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Region (2027-2033)
14.3. China
14.4. Japan
14.5. Australia
14.6. India
14.7. Rest of Asia Pacific
15. Company Profile
15.1. Abbott Diabetes Care
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Acon
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Agamatrix Inc.
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. Arkray
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. Ascensia Diabetes Care
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. Bionime Corporation
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. Dexcom
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Johnson and Johnson (Lifescan)
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Medisana
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Medtronic
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. Roche
15.11.1. Company details
15.11.2. Financial outlook
15.11.3. Product summary
15.11.4. Recent developments
15.12. Rossmax
15.12.1. Company details
15.12.2. Financial outlook
15.12.3. Product summary
15.12.4. Recent developments
15.13. Others
16. Reference Links
17. Conclusion
18. Research Scope
19. List of Abbreviations
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
